ST 03 - Sustained Therapeutics
Alternative Names: ST03-Sustained TherapeuticsLatest Information Update: 03 Mar 2023
At a glance
- Originator Sustained Therapeutics
- Class Urologics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Genitourinary disorders
Most Recent Events
- 11 Jan 2023 Preclinical trials in Genitourinary disorders in Canada (unspecified route) (Sustained Therapeutics pipeline, January 2023)
- 11 Jan 2023 Sustained Therapeutics plans a phase I trial for Urogenital cancer in Canada (Sustained Therapeutics pipeline, January 2023)